International Network Receives Grant to Combat Malaria Drug Resistance

LONDON -- An international network of malaria scientists is to be established to map the emergence of resistance to antimalarial drugs and guide global efforts to control and eradicate the disease, thanks to a $20m (£12.5m) grant from the Bill & Melinda Gates Foundation.

The WorldWide Antimalarial Resistance Network (WWARN), which will be administered and supported from Oxford University, will provide the comprehensive and rigorous evidence base needed for policy makers to select the best antimalarial treatments and to formulate strategies to control the critical problem of resistance wherever it arises.

To read the full press release, visit the University of Oxford's web site.

###
Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Jeff Raikes and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.

ONLINE RESOURCES

WWARN
Centre for Tropical Medicine

PRESS RELEASES

Feb 01, 2012Gates Foundation Invites Public to Explore New Visitor Center Jan 30, 2012Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020 Jan 26, 2012Foundation Commits $750 Million to Global Fund